Direct-to-consumer Disease Risk and Health Test and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Direct-to-consumer Disease Risk and Health Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Direct-to-consumer Disease Risk and Health Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Direct-to-consumer Disease Risk and Health Test Overall Market Size
2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size: 2021 VS 2028
2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Direct-to-consumer Disease Risk and Health Test Players in Global Market
3.2 Top Global Direct-to-consumer Disease Risk and Health Test Companies Ranked by Revenue
3.3 Global Direct-to-consumer Disease Risk and Health Test Revenue by Companies
3.4 Top 3 and Top 5 Direct-to-consumer Disease Risk and Health Test Companies in Global Market, by Revenue in 2021
3.5 Global Companies Direct-to-consumer Disease Risk and Health Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Players in Global Market
3.6.1 List of Global Tier 1 Direct-to-consumer Disease Risk and Health Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Direct-to-consumer Disease Risk and Health Test Market Size Markets, 2021 & 2028
4.1.2 Celiac Disease
4.1.3 Parkinson Disease
4.1.4 Alzheimer Disease
4.1.5 Other
4.2 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
4.2.1 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
4.2.2 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
4.2.3 By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Direct-to-consumer Disease Risk and Health Test Market Size, 2021 & 2028
5.1.2 Online
5.1.3 Offline
5.2 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
5.2.1 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
5.2.2 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
5.2.3 By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Direct-to-consumer Disease Risk and Health Test Market Size, 2021 & 2028
6.2 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue & Forecasts
6.2.1 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2022
6.2.2 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue, 2023-2028
6.2.3 By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.3.2 US Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.3.3 Canada Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.3.4 Mexico Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.4.2 Germany Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.3 France Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.4 U.K. Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.5 Italy Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.6 Russia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.7 Nordic Countries Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.4.8 Benelux Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.5.2 China Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.3 Japan Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.4 South Korea Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.5 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.5.6 India Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.6.2 Brazil Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.6.3 Argentina Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028
6.7.2 Turkey Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.3 Israel Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.4 Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
6.7.5 UAE Direct-to-consumer Disease Risk and Health Test Market Size, 2017-2028
7 Players Profiles
7.1 23andMe
7.1.1 23andMe Corporate Summary
7.1.2 23andMe Business Overview
7.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.1.4 23andMe Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.1.5 23andMe Key News
7.2 MyHeritage
7.2.1 MyHeritage Corporate Summary
7.2.2 MyHeritage Business Overview
7.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.2.5 MyHeritage Key News
7.3 LabCorp
7.3.1 LabCorp Corporate Summary
7.3.2 LabCorp Business Overview
7.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.3.4 LabCorp Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.3.5 LabCorp Key News
7.4 Myriad Genetics
7.4.1 Myriad Genetics Corporate Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.4.5 Myriad Genetics Key News
7.5 Ancestry.com
7.5.1 Ancestry.com Corporate Summary
7.5.2 Ancestry.com Business Overview
7.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.5.5 Ancestry.com Key News
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Corporate Summary
7.6.2 Quest Diagnostics Business Overview
7.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.6.5 Quest Diagnostics Key News
7.7 Gene By Gene
7.7.1 Gene By Gene Corporate Summary
7.7.2 Gene By Gene Business Overview
7.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.7.5 Gene By Gene Key News
7.8 DNA Diagnostics Center
7.8.1 DNA Diagnostics Center Corporate Summary
7.8.2 DNA Diagnostics Center Business Overview
7.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.8.5 DNA Diagnostics Center Key News
7.9 Invitae
7.9.1 Invitae Corporate Summary
7.9.2 Invitae Business Overview
7.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.9.4 Invitae Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.9.5 Invitae Key News
7.10 IntelliGenetics
7.10.1 IntelliGenetics Corporate Summary
7.10.2 IntelliGenetics Business Overview
7.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.10.5 IntelliGenetics Key News
7.11 Ambry Genetics
7.11.1 Ambry Genetics Corporate Summary
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.11.5 Ambry Genetics Key News
7.12 Living DNA
7.12.1 Living DNA Corporate Summary
7.12.2 Living DNA Business Overview
7.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.12.4 Living DNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.12.5 Living DNA Key News
7.13 EasyDNA
7.13.1 EasyDNA Corporate Summary
7.13.2 EasyDNA Business Overview
7.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.13.4 EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.13.5 EasyDNA Key News
7.14 Pathway Genomics
7.14.1 Pathway Genomics Corporate Summary
7.14.2 Pathway Genomics Business Overview
7.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.14.4 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.14.5 Pathway Genomics Key News
7.15 Centrillion Technology
7.15.1 Centrillion Technology Corporate Summary
7.15.2 Centrillion Technology Business Overview
7.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.15.4 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.15.5 Centrillion Technology Key News
7.16 Xcode
7.16.1 Xcode Corporate Summary
7.16.2 Xcode Business Overview
7.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.16.4 Xcode Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.16.5 Xcode Key News
7.17 Color Genomics
7.17.1 Color Genomics Corporate Summary
7.17.2 Color Genomics Business Overview
7.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.17.4 Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.17.5 Color Genomics Key News
7.18 Anglia DNA Services
7.18.1 Anglia DNA Services Corporate Summary
7.18.2 Anglia DNA Services Business Overview
7.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.18.4 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.18.5 Anglia DNA Services Key News
7.19 African Ancestry
7.19.1 African Ancestry Corporate Summary
7.19.2 African Ancestry Business Overview
7.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.19.4 African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.19.5 African Ancestry Key News
7.20 Canadian DNA Services
7.20.1 Canadian DNA Services Corporate Summary
7.20.2 Canadian DNA Services Business Overview
7.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.20.4 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.20.5 Canadian DNA Services Key News
7.21 DNA Family Check
7.21.1 DNA Family Check Corporate Summary
7.21.2 DNA Family Check Business Overview
7.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.21.4 DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.21.5 DNA Family Check Key News
7.22 Alpha Biolaboratories
7.22.1 Alpha Biolaboratories Corporate Summary
7.22.2 Alpha Biolaboratories Business Overview
7.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.22.4 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.22.5 Alpha Biolaboratories Key News
7.23 Test Me DNA
7.23.1 Test Me DNA Corporate Summary
7.23.2 Test Me DNA Business Overview
7.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.23.4 Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.23.5 Test Me DNA Key News
7.24 23 Mofang
7.24.1 23 Mofang Corporate Summary
7.24.2 23 Mofang Business Overview
7.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.24.4 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.24.5 23 Mofang Key News
7.25 Genetic Health
7.25.1 Genetic Health Corporate Summary
7.25.2 Genetic Health Business Overview
7.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.25.4 Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.25.5 Genetic Health Key News
7.26 DNA Services of America
7.26.1 DNA Services of America Corporate Summary
7.26.2 DNA Services of America Business Overview
7.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.26.4 DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.26.5 DNA Services of America Key News
7.27 Shuwen Health Sciences
7.27.1 Shuwen Health Sciences Corporate Summary
7.27.2 Shuwen Health Sciences Business Overview
7.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.27.4 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.27.5 Shuwen Health Sciences Key News
7.28 Mapmygenome
7.28.1 Mapmygenome Corporate Summary
7.28.2 Mapmygenome Business Overview
7.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.28.4 Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.28.5 Mapmygenome Key News
7.29 Full Genomes
7.29.1 Full Genomes Corporate Summary
7.29.2 Full Genomes Business Overview
7.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Major Product Offerings
7.29.4 Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue in Global Market (2017-2022)
7.29.5 Full Genomes Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Direct-to-consumer Disease Risk and Health Test Market Opportunities & Trends in Global Market
Table 2. Direct-to-consumer Disease Risk and Health Test Market Drivers in Global Market
Table 3. Direct-to-consumer Disease Risk and Health Test Market Restraints in Global Market
Table 4. Key Players of Direct-to-consumer Disease Risk and Health Test in Global Market
Table 5. Top Direct-to-consumer Disease Risk and Health Test Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Direct-to-consumer Disease Risk and Health Test Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Companies, 2017-2022
Table 8. Global Companies Direct-to-consumer Disease Risk and Health Test Product Type
Table 9. List of Global Tier 1 Direct-to-consumer Disease Risk and Health Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Direct-to-consumer Disease Risk and Health Test Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Direct-to-consumer Disease Risk and Health Test Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2023-2028
Table 30. 23andMe Corporate Summary
Table 31. 23andMe Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 32. 23andMe Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 33. MyHeritage Corporate Summary
Table 34. MyHeritage Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 35. MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 36. LabCorp Corporate Summary
Table 37. LabCorp Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 38. LabCorp Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 39. Myriad Genetics Corporate Summary
Table 40. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 41. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 42. Ancestry.com Corporate Summary
Table 43. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 44. Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 45. Quest Diagnostics Corporate Summary
Table 46. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 47. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 48. Gene By Gene Corporate Summary
Table 49. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 50. Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 51. DNA Diagnostics Center Corporate Summary
Table 52. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 53. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 54. Invitae Corporate Summary
Table 55. Invitae Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 56. Invitae Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 57. IntelliGenetics Corporate Summary
Table 58. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 59. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 60. Ambry Genetics Corporate Summary
Table 61. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 62. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 63. Living DNA Corporate Summary
Table 64. Living DNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 65. Living DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 66. EasyDNA Corporate Summary
Table 67. EasyDNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 68. EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 69. Pathway Genomics Corporate Summary
Table 70. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 71. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 72. Centrillion Technology Corporate Summary
Table 73. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 74. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 75. Xcode Corporate Summary
Table 76. Xcode Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 77. Xcode Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 78. Color Genomics Corporate Summary
Table 79. Color Genomics Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 80. Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 81. Anglia DNA Services Corporate Summary
Table 82. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 83. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 84. African Ancestry Corporate Summary
Table 85. African Ancestry Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 86. African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 87. Canadian DNA Services Corporate Summary
Table 88. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 89. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 90. DNA Family Check Corporate Summary
Table 91. DNA Family Check Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 92. DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 93. Alpha Biolaboratories Corporate Summary
Table 94. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 95. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 96. Test Me DNA Corporate Summary
Table 97. Test Me DNA Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 98. Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 99. 23 Mofang Corporate Summary
Table 100. 23 Mofang Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 101. 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 102. Genetic Health Corporate Summary
Table 103. Genetic Health Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 104. Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 105. DNA Services of America Corporate Summary
Table 106. DNA Services of America Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 107. DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 108. Shuwen Health Sciences Corporate Summary
Table 109. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 110. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 111. Mapmygenome Corporate Summary
Table 112. Mapmygenome Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 113. Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
Table 114. Full Genomes Corporate Summary
Table 115. Full Genomes Direct-to-consumer Disease Risk and Health Test Product Offerings
Table 116. Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Direct-to-consumer Disease Risk and Health Test Segment by Type in 2021
Figure 2. Direct-to-consumer Disease Risk and Health Test Segment by Application in 2021
Figure 3. Global Direct-to-consumer Disease Risk and Health Test Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Direct-to-consumer Disease Risk and Health Test Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Direct-to-consumer Disease Risk and Health Test Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
Figure 8. By Type - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 9. By Application - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 10. By Region - Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 11. By Country - North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 12. US Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 16. Germany Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 17. France Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 24. China Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 28. India Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 30. Brazil Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share, 2017-2028
Figure 33. Turkey Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Direct-to-consumer Disease Risk and Health Test Revenue, (US$, Mn), 2017-2028
Figure 37. 23andMe Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. LabCorp Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Invitae Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Living DNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Xcode Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue Year Over Year Growth (US$, Mn) & (2017-2022)